|
CAS号: | 56985-32-1 |
英文名称: | 9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXY-METHANOPROSTAGLANDIN F2ALPHA |
英文同义词: | U-44069;9,11-epoxymethanoprostaglandin H(2);9,11-dideoxy-9A,11A-epoxymethano-*prostaglandin F;9,11-dideoxy-9α,11α-epoxymethanoprostaglandin f2α;9,11-DIDEOXY-9A,11A-EPOXYMETHANO-PROSTAG LANDIN F2A;9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXY-METHANOPROSTAGLANDIN F2ALPHA;9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXYMETHANO-PROSTA-5Z,13E-DIEN-1-OIC ACID;(5Z)-7-[(1S,4R)-5α-[(1E,3S)-3-Hydroxy-1-octenyl]-2-oxabicyclo[2.2.1]heptan-6β-yl]-5-heptenoic acid |
中文名称: | |
中文同义词: | |
CBNumber: | CB5165643 |
分子式: | C21H34O4 |
分子量: | 350.49 |
MOL File: | 56985-32-1.mol |
|
|
|
|
9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXY-METHANOPROSTAGLANDIN F2ALPHA化学性质 |
|
9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXY-METHANOPROSTAGLANDIN F2ALPHA 性质、用途与生产工艺 |
用途
U-44069 is a stable analog of the endoperoxide PGH2, and a TP receptor agonist. U-44069 stimulates shape change in human platelets without a measurable increase in [Ca2+] with an EC50 of 1.8 nM. U-440
69 has an EC50 of 3 碌M and 54 nM for platelet aggregation and phosphatidate formation in human platelets, respectively.
|
|
|
9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXY-METHANOPROSTAGLANDIN F2ALPHA 上下游产品信息 |
上游原料
|
下游产品
|
|
|
|
|
Pharmaceuticals
Intermediates & Fine Chemicals
Heterocycles
Chiral Reagents
Prostaglandins
Lipids
Fatty Acids
BioChemical
Biochemicals and Reagents
56985-32-1
U-44069
9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXY-METHANOPROSTAGLANDIN F2ALPHA
9,11-DIDEOXY-9ALPHA,11ALPHA-EPOXYMETHANO-PROSTA-5Z,13E-DIEN-1-OIC ACID
(5Z)-7-[(1S,4R)-5α-[(1E,3S)-3-Hydroxy-1-octenyl]-2-oxabicyclo[2.2.1]heptan-6β-yl]-5-heptenoic acid
9,11-epoxymethanoprostaglandin H(2)
9,11-dideoxy-9α,11α-epoxymethanoprostaglandin f2α
9,11-DIDEOXY-9A,11A-EPOXYMETHANO-PROSTAG LANDIN F2A
9,11-dideoxy-9A,11A-epoxymethano-*prostaglandin F
|